Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
EAST RUTHERFORD, N.J., Oct. 26, 2012
EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation
(NYSE: CBM) announced that third quarter 2012 financial results will be
released on Wednesday, October 31, 2012 after the market closes.
The Company will host a conference call to discuss the financial results.
Third Quarter 2012 Earnings Conference Call
When: Thursday, November 1, 2012 at 8:30 a.m. Eastern Time
Dial-in: 1-888-430-8705 for U.S.
1-719-325-2455 for International
Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Thursday, November 8, 2012
Cambrex Corporation is an innovative life sciences company that provides
products, services and technologies to accelerate the development and
commercialization of small molecule therapeutics. We offer Active
Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug
delivery products for branded and generic pharmaceuticals. Our development and
manufacturing capabilities include enzymatic biotransformations, high potency
APIs, high energy chemical synthesis, controlled substances and formulation of
finished dosage form products. For more information, please visit
SOURCE Cambrex Corporation
Contact: Stephanie LaFiura, Investor Relations Associate, +1-201-804-3037,
Press spacebar to pause and continue. Press esc to stop.